Global Market Reach Almirall operates in over 100 countries across five continents through a network of 15 global affiliates and strategic partnerships, presenting a broad distribution opportunity for pharmaceutical products and dermatological solutions.

Dermatology Focus Specializing in medical dermatology with a pipeline aimed at psoriasis, atopic dermatitis, and actinic keratosis, Almirall offers targeted treatment solutions, making it an ideal partner for companies with complementary dermatology portfolios.

Research & Innovation With a dedicated R&D center and a recent expansion into AI-driven drug discovery collaborations, Almirall is positioning itself at the forefront of dermatological therapeutics, opening avenues for joint development and early-access drug programs.

Financial Capacity Generating annual revenues between $250 million and $500 million with substantial funding of $215 million, Almirall is financially positioned to invest in new product launches, clinical trials, and strategic partnerships to scale growth.

Digital & Data Technologies Utilizing advanced digital tools like SAP, Google Ads, and AI collaborations, Almirall demonstrates a strong commitment to leveraging technology for enhanced marketing, data-driven decision making, and operational efficiency, offering opportunities for innovative sales and marketing collaborations.